Schizophrenia & Psychosis Action Alliance

Now Available: Clozapine Education Modules for Clinicians. From titration tactics to side effect management—earn free CE units with our new modules—built by and for the experts who prescribe clozapine. Evidence-based, practical guidance—designed to improve care from the first dose onward. The first of its kind, built by clinicians and people with lived experience. Secure your spot.

Clozapine Across the Spectrum with Jonathon G. Leung. Clozapine is not one-size-fits-all. From pediatrics to older adults, pregnancy to complex medical cases, each patient population brings unique considerations. Join Jonathan G. Leung as he shares practical insights from prescribing safely across special populations to managing cardiometabolic risks and medical complexity. Bring confidence to the most challenging cases. Fast. Focused. Evidence-based. Secure your spot now.

The Clozapine Rechallenge Dilemma with Dr. Robert O. Cotes. When serious adverse events occur, discontinuing clozapine may feel like the only option. But is it always the end of the road? In this module, Dr. Cotes explores when and how to safely taper or discontinue clozapine and key considerations for rechallenge after neutropenia, myocarditis, or other serious side effects. Practical answers for the toughest clozapine dilemmas. Be prepared. Be confident. Secure your spot now.

The Untapped Potential of Clozapine with Dr. John Kane. Why has one of the most effective treatments for schizophrenia been so underused? Join Dr. John Kane, renowned researcher and author of 900+ publications, as he reflects on the legacy and future of clozapine use. NIH-funded researcher Behavioral science leader Real-world strategies to move clozapine from a “last resort” treatment option History, evidence, and a call to action—all in one module. Launching soon. Be the first to know. Secure your spot now.

From Drooling to Drowsiness with Megan J. Ehret, PharmD, MS, BCPP Constipation. Hypersalivation. Fatigue. Clozapine’s side effects are real—but manageable. Megan J. Ehret, PharmD, MS, BCPP, a psychiatric pharmacist and prominent voice in clozapine advocacy and education, offers proven strategies to manage non-ANC side effects and keep patients on the path to recovery. Improve tolerability Reduce discontinuation Build trust with patients Learn how to manage what matters. Secure your spot now.

Navigating Clozapine Monitoring in a REMS-Free Era with Dr. Deanna Kelly. The FDA rules have changed—but are you ready? Join Dr. Deanna Kelly, one of the nation’s top experts on clozapine, as she guides prescribers through: Post-REMS monitoring Lab essentials Risk management without barriers Whether you’re adjusting to the REMS transition or rethinking your protocols, this module brings clarity and confidence. Practical answers from a scientific leader. Secure your spot now.